Skip to main content

Current status of treatment completion and fatality among tuberculosis patients in Spain

Buy Article:

$34.78 + tax (Refund Policy)

OBJECTIVES: To determine treatment completion among patients with tuberculosis (TB), and to analyse factors associated with treatment default and fatality.

METHODS: A prospective cohort study of patients who began treatment between 1 June 1999 and 31 May 2000 in areas where members of the SEPAR Tuberculosis and Respiratory Infections Group work. Factors associated with treatment default and fatality were studied using logistic regression, calculating odds ratios (OR) and their 95% confidence intervals (95%CI).

RESULTS: The study involved 142 physicians from 76 different hospitals who provided information on 1515 cases. Eighty-two per cent of the patients completed treatment correctly, 14% defaulted, 5% died, 0.5% failed, and 8.7% interrupted treatment due to transfer or other reasons. The variables associated with default were intravenous drug use (IVDU) (OR 6.00, 95%CI 2.59–13.89) and immigration (OR 8.57, 95%CI 3.78–19.45); sex, age, homelessness, incarceration, directly observed treatment (DOT) or hospitalisation were not associated with default. Variables found to be predictive of fatality were alcoholism (OR 6.38, 95%CI 2.09–19.48), human immunodeficiency virus (HIV) infection (OR 7.08, 95%CI 2.08–29.15) and age >64 years (OR 10, 95%CI 2.9–34.07), whereas sex, IVDU, homelessness, DOT and hospitalisation were not.

CONCLUSIONS: In industrialised countries, IVDU patients and immigrants should be targeted for DOT, while to reduce fatality rates stricter monitoring is required for patients who are alcoholic, HIV-infected, or aged >64 years.

Keywords: Spain; case-fatality ratio; completion; cure; predictors; treatment; tuberculosis

Document Type: Regular Paper

Affiliations: 1: Tuberculosis Investigation Unit of Barcelona, Servicio de Epidemiología, Agencia de Salud Pública, Barcelona, Spain 2: Hospital General Universitario de Gran Canaria ‘Dr Negrín’, Las Palmas de Gran Canaria, Spain 3: Instituto de Salud Carlos III, Madrid, Spain

Publication date: 01 April 2004

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content